Accelerating Sustainable, Low‑Carbon Transformation Across the Pharma Value Chain
ERM is proud to sponsor Pharma Sustainability Integrates 2026, taking place on 25 February 2026 in London. Hosted by Life Science Integrates, this flagship event brings together senior leaders from across the life sciences ecosystem to address one of the industry’s most urgent priorities: transforming the pharmaceutical value chain for a more sustainable, resilient future.
The event convenes decision‑makers from global pharma, regulators, innovators, and supply chain partners to explore how the industry can accelerate decarbonisation, build circularity into operations, and unlock long‑term value through sustainability‑driven transformation.
What to Expect at Pharma Sustainability Integrates 2026
The programme features:
- Keynote interviews with leaders shaping the sector’s sustainability agenda
- Debate‑driven panel sessions exploring decarbonisation, innovation, circularity, and sustainable operations
- Insights into the role of data, digitalisation, AI and automation in enabling sustainable growth
- Opportunities to connect with senior stakeholders across manufacturing, supply chain, R&D, commercial, and sustainability functions
ERM Participation
As part of our ongoing commitment to enabling sustainable operations and accelerating Scope 3 decarbonisation across the pharmaceutical sector, ERM will take an active role in this year’s event.
Richard Platt, Partner at ERM, will facilitate a high‑level session examining how companies can build environmental responsibility into every stage of development, manufacturing, and distribution. The discussion will explore practical pathways to embed sustainability deeply into complex pharma supply chains—while protecting product quality, compliance, and patient outcomes.
Maria Dall, Partner – Global Industry Lead Pharmaceutical & Healthcare, Michael Collins, Partner, Product Sustainability & Circularity, and Anisha Harris, Managing Consultant, Low Carbon Fuels & Chemicals, will be joining as delegates.
We Help Pharmaceutical Companies Decarbonize their Supply Chain
Pharma’s Scope 3 emissions represent the majority of the sector’s footprint, driven by:
- Energy‑intensive API manufacturing
- Complex global distribution networks
- Packaging materials and end‑of‑life waste
- Cold‑chain transport and logistics
ERM helps organisations move from measurement to action, combining deep technical expertise, data‑driven insights, supplier engagement, and operational implementation to deliver measurable impact across the value chain.
Our focus includes:
- Developing end‑to‑end Scope 3 decarbonisation strategies
- Engaging and upskilling suppliers across all tiers
- Embedding circular design and sustainable materials into product and packaging systems
- Leveraging digital tools and analytics to drive data‑driven decision‑making
- Integrating sustainability into operations, procurement, and manufacturing excellence programmes
